Who we are

ReproNovo was founded by a team with expertise in the reproductive medicine and women’s health space. With years of immersion in this field, we possess deep knowledge of drug development in these therapeutic areas, the treatment landscape and patient needs.

Our team has successfully brought numerous compounds to market. Drawing upon our in-depth experience in designing and executing clinical programs, we are strongly committed to bring new treatments to patients in underserved areas in reproductive medicine and women’s health.  

In pursuit of this objective, we have built a company aimed at addressing current gaps in reproductive medicine and women’s health. 

ReproNovo is headquartered in Lausanne, Switzerland, with its primary development team located in Copenhagen, Denmark and an additional development site in Barcelona, Spain.